Rouzel Pharma’s Innovative Approach to Diabetes Management

Diabetes has become one of the most pressing global health challenges, affecting millions of people worldwide and steadily increasing in prevalence. Managing this condition requires more than just controlling blood sugar levels—it demands a holistic approach that focuses on overall health, prevention of complications, and improving the quality of life of patients. Recognizing this need, Rouzel Pharma has taken a forward-looking step by adopting an innovative approach to diabetes management.

Unlike traditional treatment methods that primarily emphasize medication, Rouzel Pharma integrates advanced research, evidence-based formulations, patient-centric solutions, and lifestyle support. The company’s approach combines modern pharmaceutical expertise with a focus on safe, effective, and accessible therapies. This includes not only blood glucose regulation but also addressing associated concerns like cardiovascular health, neuropathy, immunity, and metabolic balance.

Rouzel Pharma’s innovation lies in its comprehensive vision—providing solutions that empower patients, reduce long-term complications, and create a sustainable healthcare model. By leveraging scientific advancements, quality manufacturing, and a deep understanding of patient needs, the company aims to redefine diabetes care and offer hope for healthier, more fulfilling lives.

What is DAPROZ-5

(Dapagliglozin Tablets)

DAPROZ-5 contains Dapagliflozin 5 mg, an innovative oral anti-diabetic medication from the SGLT2 inhibitor class, used for the management of Type 2 Diabetes Mellitus. It works by blocking sodium-glucose co-transporter 2 (SGLT2) in the kidneys, which reduces glucose reabsorption and promotes its excretion through urine. This unique mechanism helps in lowering blood sugar levels independently of insulin, making it a valuable option for patients requiring additional glycemic control

Benefits of DAPROZ-5

1. Effective Blood Sugar Control
   • Reduces fasting and postprandial glucose levels by increasing urinary glucose excretion.
2. Insulin-Independent Mechanism
   • Works without relying on pancreatic insulin secretion, making it effective even in patients with reduced beta-cell function.
3. Supports Weight Management
   • Helps in modest weight loss due to calorie loss from excreted glucose.
4. Blood Pressure Reduction
   • Mild diuretic effect contributes to lowering systolic blood pressure.

Why Choose DAPROZ-5

• Innovative SGLT2 inhibitor with proven clinical efficacy.
• Comprehensive benefits beyond sugar control (weight, blood pressure, heart, and kidney protection).
• Convenient once-daily dosing for better patient adherence.

What is DAPROZ-10

(Dapagliflozin Tablets)

DAPROZ-10 contains Dapagliflozin 10 mg, a highly effective oral anti-diabetic medicine belonging to the SGLT2 inhibitor class. It is designed for the management of Type 2 Diabetes Mellitus and works by reducing glucose reabsorption in the kidneys, leading to increased urinary glucose excretion. This unique insulin-independent mechanism provides consistent glycemic control and additional health benefits beyond blood sugar regulation.

Benefits of DAPROZ-10

1. Strong Glycemic Control
   • Lowers fasting and postprandial blood sugar effectively.
2. Insulin-Independent Action
   • Works even in patients with declining beta-cell function.
3. Weight Management Support
   • Promotes modest weight reduction due to calorie loss via glucose excretion.
4. Blood Pressure Reduction
   • Mild diuretic effect helps lower systolic blood pressure naturally.

Why Choose DAPROZ-10

• Advanced SGLT2 inhibitor with proven global clinical results.
• Comprehensive care beyond sugar control (heart, kidney, weight, and BP benefits).
• Convenient once-daily dose for better compliance.

What is TRIVOGEL 2.2

(GLIMIPRIDE 2 MG +METFORMIN 500 MG +VOGLIBOSE 0.3 MG)

TRIVOGEL 2.2 is a fixed-dose combination therapy designed for the effective management of Type 2 Diabetes Mellitus. It combines Glimipride (2 mg), Metformin (500 mg), and Voglibose (0.2 mg) in a single formulation, offering a comprehensive, multi-targeted approach to controlling blood glucose levels.

• Metformin works by reducing hepatic glucose production and improving insulin sensitivity.
• Glimipride stimulates the pancreas to secrete insulin effectively.
• Voglibose delays intestinal carbohydrate absorption, thereby preventing sharp post-meal sugar spikes

Benefits of TRIVOGEL 2.2

1. Holistic Glucose Management
   • Controls fasting, postprandial, and overall blood glucose levels.
2. Triple Mechanism of Action
   • Ensures better control through different pathways: insulin release, insulin sensitivity, and carbohydrate absorption.
3. Prevents Post-Meal Sugar Spikes

Voglibose helps regulate postprandial hyperglycemia effectively

Why Choose TRIVOGEL 2.2

• Triple-action formula for comprehensive diabetes control.
• Effective post-meal sugar management, reducing sudden glucose spikes.
• Trusted and recommended by healthcare professionals.
• Convenience in one tablet, reducing the pill burden for patients.

What is ZELVID-M 500

(Vidagliptin & Metformin Hydrochloride)

ZELVID-M 500 is a powerful fixed-dose combination of  Vidagliptin & Metformin Hydrochloride tablets  specially formulated for the effective management of Type 2 Diabetes Mellitus. This dual therapy targets different mechanisms of blood sugar regulation to achieve better glycemic control.

Benefits of ZELVID-M 500

1. Dual Mechanism for Better Control
   • Vildagliptin regulates insulin & glucagon balance, while Metformin improves insulin sensitivity and reduces glucose production.
2. Effective Glycemic Management
   • Provides control over both fasting and post-meal glucose levels.
3. Weight Neutral Effect
   • Unlike some other anti-diabetic drugs, this combination does not cause significant weight gain.
4. Low Risk of Hypoglycemia
   • Vildagliptin acts in a glucose-dependent manner, lowering the chances of dangerously low blood sugar.

Why Choose ZELVID-M 500

• Powerful Combination of two proven anti-diabetic agents in one tablet.
• Comprehensive Glycemic Control covering fasting, postprandial, and overall blood sugar.
• Safe and Well-Tolerated, with a low risk of hypoglycemia.

What is TANIVIA

(TENELIGLIPTIN 20MG TAB)

TANIVIA contains Teneligliptin 20 mg, a modern oral anti-diabetic medicine belonging to the DPP-4 inhibitor class. It is used for the management of Diabetes Mellitus by enhancing the activity of incretin hormones. These hormones increase insulin secretion and decrease glucagon release in a glucose-dependent manner, helping regulate blood sugar levels efficiently.

Benefits of TANIVIA – Teneligliptin 20 mg

Effective Glycemic Control

1. Lowers both fasting and post-meal blood sugar levels.

Glucose-Dependent Action

1. Reduces the risk of hypoglycemia since it acts only when blood sugar is elevated.

Improves Beta-Cell Function

1. Helps maintain pancreatic beta-cell activity for long-term diabetes management.

Weight Neutral

1. Does not cause significant weight gain, making it suitable for overweight or obese patients.

Why Choose TANIVIA – Teneligliptin 20 mg

• Modern DPP-4 Inhibitor with proven clinical efficacy.
• Convenient Once-Daily Dosing enhances patient compliance.

Safe for Long-Term Use with minimal risk of hypoglycemia

What is TANIVIA-M

(Teneligliptin 20mg & Metformin HCI (SR) 500mg Tablets)

TANIVIA-M is a fixed-dose combination tablet containing Teneligliptin 20 mg and Metformin HCl (SR) 500 mg, formulated for the management of Type 2 Diabetes Mellitus. This combination therapy provides complementary mechanisms of action to improve blood sugar control while ensuring patient safety.

Benefits of TANIVIA-M

1. Effective Glycemic Control
   • Controls fasting, postprandial, and overall blood sugar levels efficiently.
2. Dual Mechanism of Action
   • Teneligliptin enhances insulin secretion and suppresses glucagon.
   • Metformin improves insulin sensitivity and reduces hepatic glucose production.
3. Glucose-Dependent Action
   • Reduces the risk of hypoglycemia since Teneligliptin acts only when blood sugar is elevated.
4. Sustained Release Metformin
   • Provides steady blood sugar control, minimizing peaks and troughs.
5. Weight Neutral

Combination is unlikely to cause weight gain, supporting metabolic health.

Why Choose TANIVIA-M

• Advanced Dual Therapy for comprehensive Type 2 Diabetes management.
• Safe and Well-Tolerated, with minimal hypoglycemia risk.
• Once-Daily Dosing enhances patient adherence.

What is GLIMIROZ-M1

(Metformin Hydrochloride 500mg Sustained Release + Glimepride 1mg Tab)

GLIMIROZ-M1 is a fixed-dose combination tablet containing Metformin Hydrochloride 500 mg (Sustained Release) and Glimepiride 1 mg, formulated for the effective management of Type 2 Diabetes Mellitus. This combination therapy targets multiple mechanisms of blood sugar control to provide comprehensive glycemic management.

Benefits of GLIMIROZ-M1

1. Dual Mechanism of Action
   • Metformin improves insulin sensitivity and reduces glucose production.
   • Glimepiride increases insulin secretion from pancreatic beta cells.
2. Effective Glycemic Control
   • Controls both fasting and postprandial blood sugar levels efficiently.
3. Sustained Release Formulation
   • Provides steady blood sugar control over an extended period, reducing the risk of peaks and troughs.
4. Convenience in One Tablet
   • Simplifies treatment by combining two effective agents into a single dose.

Why Choose GLIMIROZ-M1

• Comprehensive Diabetes Management with dual-action therapy.
• Sustained Release for Consistent Control, reducing fluctuations in blood sugar.
• Convenient One-Tablet Dose, improving patient adherence.

What is GLIMIROZ-MP2      

(Glimepride 2mg + Metformin 500mg + Pioglitaxone 15mg)

GLIMIROZ-MP2 is a triple-combination oral anti-diabetic tablet containing Glimepiride 2 mg, Metformin 500 mg, and Pioglitazone 15 mg, designed for the effective management of Type 2 Diabetes Mellitus. This formulation targets multiple mechanisms of blood sugar regulation, providing comprehensive glycemic control for patients who require more than single or dual therapy.

Benefits of GLIMIROZ-MP2

1. Triple Mechanism of Action
   • Targets glucose regulation through insulin secretion, insulin sensitivity, and hepatic glucose control.
2. Effective Glycemic Control
   • Controls fasting, postprandial, and overall blood sugar levels.
3. Improved Insulin Sensitivity
   • Pioglitazone and Metformin together enhance tissue response to insulin, reducing insulin resistance.
4. Convenient Single Tablet Therapy
   • Combines three agents in one tablet, improving patient compliance.

Why Choose GLIMIROZ-MP2

• Comprehensive Triple-Action Formula for better glycemic control.
• Convenient Single Tablet reduces pill burden and simplifies therapy.
• Clinically Proven Safety and Efficacy for Type 2 Diabetes management.

What is GLIMIROZ-MP1

(Glimepride 1mg + Metformin 500mg + Pioglitaxone 15mg) GLIMIROZ-MP1 is a triple-combination oral anti-diabetic tablet containing Glimepiride 1 mg, Metformin 500 mg, and Pioglitazone 15 mg, formulated for the effective management of Type 2 Diabetes Mellitus. This combination targets multiple mechanisms of glucose regulation to provide comprehensive and balanced glycemic control

Benefits of GLIMIROZ-MP1

1. Triple Mechanism of Action
   • Combines insulin secretion, improved insulin sensitivity, and reduced hepatic glucose production.
2. Effective Glycemic Management
   • Controls fasting, postprandial, and overall blood sugar levels efficiently.
3. Enhanced Insulin Sensitivity
   • Pioglitazone and Metformin together improve tissue response to insulin and reduce insulin resistance.
4. Convenient Single Tablet Therapy
   • Reduces pill burden and improves patient adherence.

Why Choose GLIMIROZ-MP1

• Comprehensive Triple-Action Formula for optimal blood sugar control.
• Lower Glimepiride Dose for safer use in sensitive patients.
• Convenient One-Tablet Therapy improves compliance.

What is GLIMIROZ-M2

(Metformin Hydrochloride 500mg Sustained Release + Glimepride 2mg Tab)

GLIMIROZ-M2 is a fixed-dose combination tablet containing Metformin Hydrochloride 500 mg (Sustained Release) and Glimepiride 2 mg, formulated for the management of Type 2 Diabetes Mellitus. This combination targets multiple pathways of glucose regulation to provide effective and balanced glycemic control.

Benefits of GLIMIROZ-M2

1. Dual Mechanism of Action
   • Metformin improves insulin sensitivity and reduces hepatic glucose output.
   • Glimepiride stimulates insulin secretion from pancreatic beta cells.
2. Effective Glycemic Control
   • Helps control both fasting and postprandial blood sugar efficiently.
3. Sustained Release Formulation
   • Ensures gradual and steady blood sugar control over the day.
4. Convenient Single Tablet Therapy
   • Simplifies treatment and enhances patient adherence.

Why Choose GLIMIROZ-M2

• Dual-action therapy for comprehensive diabetes management.
• Stronger Glimepiride dose compared to GLIMIROZ-M1 for enhanced control.
• Sustained release ensures consistent blood sugar regulation.

Conclusion

• Managing Type 2 Diabetes Mellitus requires effective, safe, and patient-friendly therapies that target multiple aspects of blood sugar regulation. The range of medicines discussed—TRIVOGEL, DAPROZ, ZELVID-M, TANIVIA, and GLIMIROZ series—offers advanced, evidence-based solutions tailored to diverse patient needs.
• These medicines empower healthcare professionals to provide personalized, holistic diabetes care. By choosing these advanced therapies, patients can achieve better blood sugar control, reduce the risk of complications, and improve overall quality of life.

Contact Us

For more details or to place an order:

Email: rouzelpharmapl@gmail.com

Call: 9592087880 / 8284007939

Website: www.rouzelpharma.in

You May Also Like-https://rouzelpharma.in/2025/09/16/otoqure-ear-drops-same-trusted-care-all-new-packaging-trusted-innovation-from-rouzel-pharma/